The promising roles of medicinal plants and bioactive compounds on hepatic lipid metabolism in the treatment of non-alcoholic fatty liver disease in animal models: molecular targets

被引:6
|
作者
Zakaria, Zaida [1 ]
Othman, Zaidatul Akmal [1 ,2 ]
Nna, Victor Udo [3 ]
Mohamed, Mahaneem [1 ,4 ]
机构
[1] Univ Sains Malaysia, Sch Med Sci, Dept Physiol, Hlth Campus, Kubang Kerian, Kelantan, Malaysia
[2] Univ Sultan Zainal Abidin, Fac Med, Unit Physiol, Kuala Terengganu, Malaysia
[3] Univ Calabar, Coll Med Sci, Fac Basic Med Sci, Dept Physiol, Calabar, Nigeria
[4] Univ Sains Malaysia, Sch Med Sci, Unit Integrat Med, Hlth Campus, Kubang Kerian, Kelantan, Malaysia
关键词
Medicinal plants; natural products; supplementation; hepatic lipid metabolism; non-alcoholic fatty liver disease; ELEMENT-BINDING PROTEIN-1C; ACTIVATED RECEPTOR-ALPHA; ADIPOSE TRIGLYCERIDE LIPASE; MESSENGER-RNA EXPRESSION; HORMONE-SENSITIVE LIPASE; ACETYL-COA CARBOXYLASE; DE-NOVO LIPOGENESIS; HIGH-FRUCTOSE DIET; INDUCED OBESE MICE; NF-KAPPA-B;
D O I
10.1080/13813455.2021.1939387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Imbalance in hepatic lipid metabolism can lead to an abnormal triglycerides deposition in the hepatocytes which can cause non-alcoholic fatty liver disease (NAFLD). Four main mechanisms responsible for regulating hepatic lipid metabolism are fatty acid uptake, de novo lipogenesis, lipolysis and fatty acid oxidation. Controlling the expression of transcription factors at molecular level plays a crucial role in NAFLD management. This paper reviews various medicinal plants and their bioactive compounds emphasising mechanisms involved in hepatic lipid metabolism, other important NAFLD pathological features, and their promising roles in managing NAFLD through regulating key transcription factors. Although there are many medicinal plants popularly investigated for NAFLD treatment, there is still little information and scientific evidence available and there has been no research on clinical trials scrutinised on this matter. This review also aims to provide molecular information of medicinal plants in NALFD treatment that might have potentials for future scientifically controlled studies.
引用
收藏
页码:1262 / 1278
页数:17
相关论文
共 50 条
  • [41] SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease
    Yuhan Liu
    Fudong Yu
    Yan Han
    Qing Li
    Zhujun Cao
    Xiaogang Xiang
    Shaowen Jiang
    Xiaolin Wang
    Jie Lu
    Rongtao Lai
    Hui Wang
    Wei Cai
    Shisan Bao
    Qing Xie
    Scientific Reports, 6
  • [42] Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota
    Han, Ruiting
    Qiu, Huihui
    Zhong, Jing
    Zheng, Ningning
    Li, Bingbing
    Hong, Ying
    Ma, Junli
    Wu, Gaosong
    Chen, Linlin
    Sheng, Lili
    Li, Houkai
    PHYTOMEDICINE, 2021, 85
  • [43] Hepatic RIPK3 signalling differentially modulates lipid metabolism and inflammation in non-alcoholic fatty liver disease
    Afonso, Marta B.
    Miguel Rodrigues, Pedro
    Mateus-Pinheiro, Miguel
    Simao, Andre L.
    Gaspar, Maria Manuela
    Majdi, Amine
    Ratziu, Vlad
    Banales, Jesus M.
    Gautheron, Jeremie
    Castro, Rui E.
    Rodrigues, Cecilia M. P.
    JOURNAL OF HEPATOLOGY, 2020, 73 : S672 - S672
  • [44] Fibroblast Growth Factor 19: Potential modulation of hepatic metabolism for the treatment of non-alcoholic fatty liver disease
    Sciarrillo, Christina M.
    Keirns, Bryant H.
    Koemel, Nicholas A.
    Anderson, Kendall L.
    Emerson, Sam R.
    LIVER INTERNATIONAL, 2021, 41 (05) : 894 - 904
  • [45] INSULIN RESISTANCE, LIPID METABOLISM AND FATTY ACID PROFILE IN CHILDREN WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Janczyk, W.
    Wierzbicka, A.
    Socha, P.
    Neuhoff-Murawska, J.
    Lembas, A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E152 - E153
  • [46] Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment
    Yang, Yu
    Zhao, Yu
    Li, Wenzhen
    Wu, Yuyao
    Wang, Xin
    Wang, Yijie
    Liu, Tingmei
    Ye, Tinghong
    Xie, Yongmei
    Cheng, Zhiqiang
    He, Jun
    Bai, Peng
    Zhang, Yiwen
    Ouyang, Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 197
  • [47] Hepatic lipid saturation indices and insulin resistance in non-alcoholic fatty liver disease (NAFLD)
    Haus, Jacob M.
    Solomon, Thomas P. J.
    Lu, Lan
    McCullough, Arthur J.
    Flask, Chris A.
    Kirwan, John P.
    FASEB JOURNAL, 2010, 24
  • [48] How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
    Geng, Yana
    Faber, Klaas Nico
    de Meijer, Vincent E.
    Blokzijl, Hans
    Moshage, Han
    HEPATOLOGY INTERNATIONAL, 2021, 15 (01) : 21 - 35
  • [49] Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats
    Hussein, Osamah
    Grosovski, Masha
    Lasri, Etti
    Svalb, Sergio
    Ravid, Uzi
    Assy, Nimer
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (03) : 361 - 368
  • [50] How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
    Yana Geng
    Klaas Nico Faber
    Vincent E. de Meijer
    Hans Blokzijl
    Han Moshage
    Hepatology International, 2021, 15 : 21 - 35